What Lymphoma Canada does

Lymphoma Canada is a registered Canadian charitable non-profit organization (Charitable Number: 873461040RR0001) headquartered in Mississauga, Ontario, and the only national organization in Canada dedicated exclusively to Hodgkin lymphoma, Non-Hodgkin lymphoma, Chronic Lymphocytic Leukemia (CLL), and Small Lymphocytic Lymphoma (SLL). Founded circa 2000, the organization celebrated its 25th anniversary in 2025 and serves patients, caregivers, healthcare professionals, and the broader healthcare system through four pillars: education, support, advocacy, and research funding. It states it represents lymphoma patients in 100% of Canada's Health Technology Assessment (HTA) reviews, giving it a unique role in drug access and reimbursement deliberations.

The organization delivers its mission through a digital-first portfolio of free resources: comprehensive PDF patient guides for Hodgkin lymphoma, Non-Hodgkin lymphoma, and CLL/SLL; the CLL Watch & Wait Tracker mobile and web application (Android and Apple); bilingual (English/French) educational webinars and videos; the Lymphoma Community social platform; a peer-to-peer mentorship program; and the co-facilitated Lymphoma Canada Wellspring Support Group. It also funds lymphoma research and provides clinical-trial information, treatment guidelines, and diagnostic algorithms to healthcare professionals. All services are provided at no cost to end users.

Lymphoma Canada is funded entirely through donations and fundraising rather than paid services. Revenue streams include individual donations (including the Partners in Giving monthly program), major foundation gifts (e.g., Vohra-Miller Foundation, Strangers in the Night Foundation), signature events such as the Par for the Cure Annual Golf Tournament (15th edition in 2026) and Laps Around Lymphoma, planned giving and legacy donations, gifts of securities, and payroll giving. Operations are supported by a small team (1–10 employees), a Board of Directors, a Scientific Advisory Board, and a volunteer network, with go-to-market executed via an event- and community-led model rather than a sales motion.

Name

Lymphoma Canada

Legal name

Lymphoma Canada

Website

https://lymphoma.ca

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Lymphoma Canada is a national Canadian non-profit organization dedicated exclusively to supporting Hodgkin lymphoma, Non-Hodgkin lymphoma, and CLL/SLL patients, caregivers, and healthcare professionals through free bilingual education, peer support, research funding, and advocacy in drug access reviews.

Ownership category

akta.pro rank

Product category

Nonprofit Patient Advocacy and Education

NAICS

Voluntary Health Organizations (813212), Social Advocacy Organizations (8133), Individual and Family Services (6241)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Social Services (8300), Services-Educational Services (8200)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industry

Community Health, Prevention & Health Education (BPAGACAC)

Keywords

• Lymphoma patient education
• Cancer patient advocacy
• Patient support programs
• Lymphoma research funding
• Nonprofit health organization

Headquarters

HQ city

Mississauga

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations and Fundraising: Primary revenue stream through individual donations, major gifts, monthly giving (Partners in Giving program), and event-based fundraising including golf tournaments, raffles, and community events.
2. Planned Giving and Legacy Donations: Legacy giving options including bequests, life insurance donations, charitable remainder trusts, and gifts of residual interest.
3. Gifts of Securities: Donors can contribute publicly traded securities as donations.
4. Payroll Giving: Employees can donate through payroll deduction programs.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Lymphoma Canada is a national charitable nonprofit that provides free disease-specific education, patient support services, advocacy, and research funding for individuals affected by Hodgkin lymphoma, Non-Hodgkin lymphoma, Chronic Lymphocytic Leukemia (CLL), and Small Lymphocytic Lymphoma (SLL). Its core offerings include patient education guides, peer mentorship, support groups, an Ask-a-Specialist service, educational webinars, the CLL Watch & Wait Tracker mobile/web app, and participation in Canadian Health Technology Assessment reviews to influence treatment access.

Product overview

Lymphoma Canada operates as a patient advocacy and education organization offering a comprehensive portfolio of resources and digital tools for lymphoma patients, caregivers, and healthcare professionals. The core offerings include patient guide PDFs (Hodgkin Lymphoma Patient Guide, Non-Hodgkin Lymphoma Patient Guide, CLL & SLL Patient Guide) providing disease-specific education, supplemented by the CLL Watch & Wait Tracker mobile/web application for symptom monitoring. The organization provides direct patient support through Ask a Lymphoma/CLL Specialist, Peer-to-Peer Mentorship Program, and support groups including the Lymphoma Canada Wellspring Support Group. Healthcare professionals benefit from treatment guidelines, diagnostic algorithms, and research funding opportunities. Educational content is delivered through videos, webinars, and the Know Your Nodes educational quiz tool.

Differentiator

Problem solved

Functional benefit

Products and services

• Hodgkin Lymphoma Patient Guide A comprehensive PDF patient education guide covering signs and symptoms, subtypes, diagnosis, staging, and treatment options for Hodgkin lymphoma, made available for free download by lymphoma patients and caregivers in Canada.
• Non-Hodgkin Lymphoma Patient Guide A comprehensive PDF patient education guide covering non-Hodgkin lymphoma subtypes, classification, grading, and treatment options including CAR-T therapy, biologics, chemotherapy, radiation, stem cell transplant, and side effect management, offered free of charge.
• CLL & SLL Patient Guide A PDF patient education guide providing detailed information on Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL), including diagnosis, lab tests, staging, treatment options, and the watch and wait approach, provided free to patients and caregivers.
• CLL Watch & Wait Tracker A mobile (Android and Apple) and web application that helps CLL and SLL patients monitor their symptoms during the watch and wait phase of their disease, provided free of charge by Lymphoma Canada.
• Peer-to-Peer Mentorship Program A mentorship program that connects lymphoma and CLL patients and their caregivers with experienced peer mentors for one-on-one support and guidance throughout diagnosis, treatment, and survivorship.
• Lymphoma Canada Wellspring Support Group A structured support group program for lymphoma patients and caregivers, facilitated in partnership with Wellspring, offering peer-led educational and emotional support sessions.
• Ask a Lymphoma/CLL Specialist A free service that connects lymphoma and CLL patients and caregivers with specialist physicians to receive answers to their disease and treatment questions.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Lymphoma CoalitioncoreStrategic or Co-development PartnerLymphoma Canada is a member of the Lymphoma Coalition, a global network of lymphoma patient organizations. Through this membership, they participate in the Standards of Excellence Program covering Info-Standards, Financial Accountability and Fundraising, Governance, and Organisational Process standards.
• WellspringcoreStrategic or Co-development PartnerPartnership for the Lymphoma Canada Wellspring Support Group, providing structured peer support and educational sessions for lymphoma patients and caregivers.
• Healthcare Institutions and Research CenterscoreStrategic or Co-development PartnerCollaboration with hospitals, cancer centers, and research institutions across Canada for clinical trial information, treatment guidelines development, and healthcare professional education.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Blood Cancer UK: UK-based charity focused on blood cancer research and patient support. Direct international peer in disease focus, research funding strategy, and patient education offerings.
• Lymphoma Research Foundation (LRF): US-based nonprofit exclusively focused on lymphoma research funding and patient education. Closest category match in scope and mission, including research grants, treatment-guideline dissemination, and patient support programs.
• CLL Society: US-based nonprofit focused specifically on chronic lymphocytic leukemia, providing patient education, support groups, and clinical trial navigation — directly mirroring Lymphoma Canada's CLL/SLL focus and Watch & Wait patient resources.
• Leukemia & Lymphoma Society (LLS): The largest US nonprofit dedicated to blood cancer (leukemia, lymphoma, myeloma) research and patient support. Most direct international peer given overlapping disease focus, patient education, peer support, and HTA-adjacent advocacy work.

Broad incumbents

• Canadian Cancer Society: Canada's largest cancer charity with broad (all-cancer) mandate. Competes for the same donors, federal grants, and HTA patient-input opportunities, but does not specialize in lymphoma.

Others

• Health Canada / Canadian Agency for Drugs and Technologies in Health (CADTH): The HTA body in which Lymphoma Canada holds representation. Not a competitor but a critical ecosystem counterpart — useful peer for understanding the regulatory infrastructure that underpins Lymphoma Canada's HTA moat.
• Lymphoma Coalition: Global umbrella network of which Lymphoma Canada is a member. Operates the Standards of Excellence Program referenced in the company's recognitions. Comparable as an ecosystem orchestrator and peer network rather than direct service competitor.

Regional players

• Colorectal Cancer Canada: Canadian disease-specific cancer nonprofit operating in the same country with a similar model of patient education, advocacy, and research funding. Useful peer for benchmarking Canadian disease-specific nonprofit scale and donor engagement.
• Lung Cancer Canada: Another Canadian disease-specific cancer charity with comparable patient education, advocacy, and fundraising structure. Comparable in operational model, headcount class, and Canadian HTA engagement.

Emerging players

• Wellspring Cancer Support: Canadian cancer support organization already partnered with Lymphoma Canada via the Wellspring Support Group. Comparable in mission (peer support, education) and overlapping programs in cancer care, but operates across multiple cancer types.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/lymphomacanada
• YouTubeyoutube.com/LymphomaTV
• Facebookfacebook.com/LymphomaCanada
• LinkedInlinkedin.com/company/lymphoma-canada
• Instagraminstagram.com/lymphomacanada

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lymphoma Canada